Assertio to acquire Spectrum Pharmaceuticals | Crain's Chicago Business
The all-stock deal would bring oncology drug Rolvedon into Assertio's drug portfolio.
Source: chicagobusiness.com
Boston Based Spectrum News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Boston Based Spectrum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Boston Based Spectrum Today - Breaking & Trending Today
Biotech Firm Slashes 75% of Staff After FDA Rejects Drug for Rare Lung Cancer
In rejecting Spectrum Pharmaceuticals drug poziotinib, the FDA said the biotech needs to generate more data from another clinical trial. Instead, Spectrum is turning the company’s focus to commercializing its recently approved product for treating a common cancer complication.
Source: medcitynews.com
FDA advisory committee issues back to back negative votes on two cancer drugs
Spectrum Pharmaceuticals and Oncopeptides each received separate negative advisory committee votes for their respective cancer drugs. In other recent regulatory news, clinical trial holds were placed and lifted and the FDA is seeking public comment on its draft guidance for including children in clinical trials.
Source: medcitynews.com